InspireMD Inc.InspireMD Inc.InspireMD Inc.

InspireMD Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪79.92 M‬EUR
−0.706EUR
‪−30.92 M‬EUR
‪6.77 M‬EUR
‪19.85 M‬
Beta (1Y)
−0.43
Employees (FY)
86
Change (1Y)
+20 +30.30%
Revenue / Employee (1Y)
Net income / Employee (1Y)

About InspireMD Inc.


CEO
Marvin L. Slosman
Headquarters
Miami
Founded
2005
ISIN
US45779A8466
FIGI
BBG00JQ9BNM3
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

Check out other big names from the same industry as II2.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange InspireMD Inc. stocks are traded under the ticker II2.
We've gathered analysts' opinions on InspireMD Inc. future price: according to them, II2 price has a max estimate of 4.25 EUR and a min estimate of 3.40 EUR. Watch II2 chart and read a more detailed InspireMD Inc. stock forecast: see what analysts think of InspireMD Inc. and suggest that you do with its stocks.
II2 reached its all-time high on Apr 30, 2015 with the price of 107.580 EUR, and its all-time low was 0.803 EUR and was reached on Nov 10, 2022. View more price dynamics on II2 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track InspireMD Inc. financials in yearly and quarterly reports right on TradingView.
InspireMD Inc. is going to release the next earnings report on Nov 4, 2025. Keep track of upcoming events with our Earnings Calendar.
II2 earnings for the last quarter are −0.22 EUR per share, whereas the estimation was −0.22 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are −0.17 EUR per share. See more details about InspireMD Inc. earnings.
InspireMD Inc. revenue for the last quarter amounts to ‪1.51 M‬ EUR, despite the estimated figure of ‪1.29 M‬ EUR. In the next quarter, revenue is expected to reach ‪1.50 M‬ EUR.
II2 net income for the last quarter is ‪−11.16 M‬ EUR, while the quarter before that showed ‪−10.32 M‬ EUR of net income which accounts for −8.16% change. Track more InspireMD Inc. financial stats to get the full picture.
No, II2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 4, 2025, the company has 86 employees. See our rating of the largest employees — is InspireMD Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. InspireMD Inc. EBITDA is ‪−35.62 M‬ EUR, and current EBITDA margin is −469.82%. See more stats in InspireMD Inc. financial statements.
Like other stocks, II2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade InspireMD Inc. stock right from TradingView charts — choose your broker and connect to your account.